Taysha Gene Therapies Inc. has granted three new employees a total of 349,000 restricted stock units (RSUs) as part of their employment agreements. The RSUs will vest in four equal annual installments starting on the first anniversary of the vesting commencement date, contingent upon each employee’s continued service with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Taysha Gene Therapies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9650074-en) on February 06, 2026, and is solely responsible for the information contained therein.